[Federal Register Volume 62, Number 98 (Wednesday, May 21, 1997)]
[Notices]
[Page 27776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13312]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 17, 1997, Research 
Biochemicals, Limited Partnership, 1-3 Strathmore Road, Natick, 
Massachusetts 01760, made application to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                   Drug                               Schedule          
------------------------------------------------------------------------
Cathinone (1235).........................  I                            
Methcathinone (1237).....................  I                            
Alpha-Ethyltryptamine (7249).............  I                            
Lysergic acid diethylamide (7315)........  I                            
2,5-Dimethoxyamphetamine (7396)..........  I                            
3,4-Methylenedioxymethamphetamine (7405).  I                            
Dimethyltryptamine (7435)................  I                            
1-[-(2-Thienyl) cyclohexyl] piperidene     I                            
 (7470).                                                                
Heroin (9200)............................  I                            
Normorphine (9313).......................  I                            
Phencyclidine (7471).....................  II                           
Benzoylecgonine (9180)...................  II                           
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
laboratory reference standards and neurochemicals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application. Any such comments or 
objections may be addressed, in quintuplicate, to the Acting Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, United States Department of Justice, Washington, D.C. 
20537, Attention: DEA Federal Register Representative (CCR), and must 
be filed no later than July 21, 1997.

    Dated: April 24, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. 97-13312 Filed 5-20-97; 8:45 am]
BILLING CODE 4410-09-M